Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Uncover effective ways to increase points on credit cards and watch your rewards grow. Start optimizing your spending today.
18,895 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
AI data centers demand rock-solid power and long-term service, not hype. This boring industrial stock quietly bankrol...
IBM stock surged, led by advances in quantum computing and open-source software. This in-depth look explains what spu...
A mobility startup defies the VC playbook, raising $15 million from private investors. The story highlights disciplin...
SoFi Technologies jumps after unveiling SoFiUSD, a bank-issued stablecoin with Mastercard settlement integration, fue...
Synopsys posted solid quarterly results but faces Design IP headwinds. The path to a 2027 price target hinges on marg...
Despite regulatory progress and new market access, XRP has struggled to break out in 2026. This piece analyzes whethe...
If the market sinks tomorrow, one AI stock stands out as a compelling buy due to a durable moat, strong cash flow, an...
When a top executive sells shares after exercising options, markets take note. This deep dive breaks down Kalvista's ...
A highly focused 3x Korea fund rides a memory-chip demand wave to striking gains, but risk factors and regulatory scr...
NIO posted a 62% year-over-year jump in May deliveries, sending stock higher as it rolls out new models. Tesla edged ...
When a fund sells a big stake in Champion Homes, it can reveal more about market sentiment than a quarterly report. T...